World's Best Scientists 2026 revealed!
Richard M. Watson

Richard M. Watson

D-Index & Metrics

Immunology

D-Index
54
Citations
8455
World Ranking
3915
National Ranking
99

Richard M. Watson publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Richard M. Watson sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 120 publications — 7th percentile

7% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Richard M. Watson D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Richard M. Watson sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 54 D-Index — 22nd percentile

22% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Richard M. Watson is primarily affiliated with McMaster University in Canada. Their research is situated within the broad discipline of Biochemistry, Genetics, and Molecular Biology, with a specific focus on Molecular Biology and Cancer Research at the subfield level.

The scientist's recent publications have examined RNA modifications and their biological implications, particularly in relation to RNA secondary structure prediction. Two notable papers include:

  • "Secondary structure prediction for RNA sequences including N6-methyladenosine," published in 2022 in Nature Communications
  • "Secondary Structure Prediction for RNA Sequences Including N6-methyladenosine," published in 2021 in bioRxiv (Cold Spring Harbor Laboratory)

The work predominantly addresses main topics such as:

  • RNA modifications and cancer
  • RNA and protein synthesis mechanisms
  • RNA research and splicing
  • Cancer-related molecular mechanisms research

The scientist frequently collaborates with several coauthors over multiple projects. These include:

  • Elżbieta Kierzek
  • Xiaoju Zhang
  • Ryszard Kierzek
  • David H. Mathews
  • Scott D. Kennedy

Richard M. Watson's papers are published primarily in venues that reflect their research focus, such as:

  • Nature Communications
  • bioRxiv (Cold Spring Harbor Laboratory)

The fields and topics associated with their work illustrate a convergence of molecular biology techniques and cancer research, emphasizing the role of RNA modifications in cellular processes. This intersection highlights investigations into how chemical modifications of RNA impact secondary structure and influence mechanisms of protein synthesis and disease progression.

No record of awards or book publications is indicated in the available information.

Best Publications

  • Inhibition of Exercise-Induced Bronchoconstriction by MK-571, a Potent Leukotriene D4–Receptor Antagonist

    Patrick J. Manning;Richard M. Watson;Dorothy J. Margolskee;Vanessa C. Williams

  • Allergen-induced increases in IL-5 receptor alpha-subunit expression on bone marrow-derived CD34+ cells from asthmatic subjects. A novel marker of progenitor cell commitment towards eosinophilic differentiation.

    R Sehmi;L J Wood;R Watson;R Foley

  • Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthma

    Gail M. Gauvreau;Louis Philippe Boulet;Donald W. Cockcroft;J. Mark Fitzgerald

  • Protective effects of inhaled PGE2 on allergen-induced airway responses and airway inflammation.

    Gail M. Gauvreau;Rick M. Watson;Paul M. O'byrne

  • Changes in the cellular profile of induced sputum after allergen-induced asthmatic responses.

    Isabelle Pin;Andreas P. Freitag;Paul M. O'Byrne;Adele Girgis-Gabardo

  • Kinetics of Allergen-Induced Airway Eosinophilic Cytokine Production and Airway Inflammation

    Gail M. Gauvreau;Rick M. Watson;Paul M. O'byrne

  • Increased Numbers of Both Airway Basophils and Mast Cells in Sputum after Allergen Inhalation Challenge of Atopic Asthmatics

    Gail M. Gauvreau;Jong M. Lee;Richard M. Watson;Anne-Marie A. Irani

  • Effect of inhaled PGE2 on exercise-induced bronchoconstriction in asthmatic subjects.

    Enrico Melillo;Karen L. Woolley;Patrick J. Manning;Richard M. Watson

  • Changes in Bone Marrow Inflammatory Cell Progenitors after Inhaled Allergen in Asthmatic Subjects

    Lorna J. Wood;Mark D. Inman;Richard M. Watson;Ronan Foley

  • Antisense therapy against CCR3 and the common beta chain attenuates allergen-induced eosinophilic responses.

    Gail M. Gauvreau;Louis Philippe Boulet;Donald W. Cockcroft;Adrian Baatjes

  • Effects of inhaled budesonide on allergen-induced airway responses and airway inflammation.

    G M Gauvreau;J Doctor;R M Watson;M Jordana

  • Allergen-induced Increases in Sputum Levels of Group 2 Innate Lymphoid Cells in Subjects with Asthma.

    Ruchong Chen;Ruchong Chen;Steven G Smith;Brittany Ma Salter;Amani El-Gammal

  • Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects

    Allan Hamilton;Isidore Faiferman;Paul Stober;Richard M. Watson

  • β2-Agonist Tolerance and Exercise-induced Bronchospasm

    Robert J. Hancox;Padmaja Subbarao;Dennis Kamada;Richard M. Watson

  • Effect of Regular Inhaled Albuterol on Allergen-induced Late Responses and Sputum Eosinophils in Asthmatic Subjects

    G. M. Gauvreau;M. Jordana;R. M. Watson;D. W. Cockcroft

  • Inhaled Leukotriene E4, But Not Leukotriene D4, Increased Airway Inflammatory Cells in Subjects with Atopic Asthma

    Gail M. Gauvreau;Krishnan N. Parameswaran;Richard M. Watson;Paul M. O'byrne

  • Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen-induced early asthmatic responses

    Gail M. Gauvreau;Jonathan P. Arm;Louis-Philippe Boulet;Richard Leigh

  • Effects of montelukast and budesonide on airway responses and airway inflammation in asthma.

    Richard Leigh;Dilini Vethanayagam;Makoto Yoshida;Richard M. Watson

  • Symptom Perception during Acute Bronchoconstriction

    Kieran J. Killian;Richard Watson;Joceline Otis;Timothy A. St. Amand

  • Allergen-induced fluctuation in CC chemokine receptor 3 expression on bone marrow CD34+ cells from asthmatic subjects: significance for mobilization of haemopoietic progenitor cells in allergic inflammation

    Roma Sehmi;Sandra Dorman;Adrian Baatjes;Rick Watson

  • 440 Changes in the cellular profile of inducedsputum after allergen-induced asthmatic responses

    Isabelle Pin;Andy Freitag;Paul M. O'Byrne;Adele Girgis-Gabardo

Frequent Co-Authors

Paul M. O'Byrne
Paul M. O'Byrne McMaster University
Gail M. Gauvreau
Gail M. Gauvreau McMaster University
Donald W. Cockcroft
Donald W. Cockcroft University of Saskatchewan
Judah A. Denburg
Judah A. Denburg McMaster University
Mark D. Inman
Mark D. Inman McMaster University
Louis-Philippe Boulet
Louis-Philippe Boulet Université Laval
J. Mark FitzGerald
J. Mark FitzGerald University of British Columbia
John W. Upham
John W. Upham University of Queensland
Mark Larché
Mark Larché McMaster University
Qutayba Hamid
Qutayba Hamid University of Sharjah

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise in Immunology, pursuing related online degrees and certifications can open diverse career opportunities. Many healthcare professionals transition to specialized roles through structured programs designed to fit busy schedules.

Nurses aiming to deepen their clinical skills might consider fnp to acute care certification programs. These certifications enable Family Nurse Practitioners to manage more complex patient needs, which can be essential in immunology-focused healthcare settings.

Accelerated degree options, such as accelerated rn to np programs, allow Registered Nurses to quickly attain Nurse Practitioner status. This pathway is beneficial for those looking to engage more directly in patient care or research within immunology.

For individuals without a nursing background, online absn programs for non nurses offer a flexible route to enter the nursing field. These programs prepare students for nursing roles that intersect with immunology research and clinical application.

Additionally, students might explore easiest accelerated nursing programs to find accessible options that fit their personal and professional lives. Such programs can be an efficient starting point for careers combining nursing and immunology.

Best Scientists Citing Richard M. Watson

Trending Scientists

Recently Published Articles